Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2025-01-29 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 72% confidence The document is a Form 52-109FV1 “Venture Issuer Basic Certificate,” which is a regulatory certification by the CEO confirming review and fair presentation of annual filings under Canadian NI 52-109. It is not an annual report, MD&A, earnings release, or shareholder vote result, nor is it merely announcing the publication of a report. It is a regulatory compliance filing without financial details. Therefore it falls under the fallback category “Regulatory Filings” (RNS).
2025-01-29 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 90% confidence The document is a Form 52-109FV1 Certification of Annual Filings under Canadian NI 52-109, signed by the CFO certifying the annual filings. It is not the annual report itself but a regulatory certificate filing. It does not fall under any specific categories such as Annual Report (10-K), Audit Report (AR), or any voting/dividend announcements. Therefore, this is best classified as a general regulatory filing (RNS).
2025-01-29 English
Material change report - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a Canadian securities ‘FORM 51-102F3 Material Change Report’ filed on SEDAR+ that primarily discloses the closing of the second tranche of a non-brokered private placement (issuance of units comprising shares and warrants) and a debt settlement via share issuance. This is clearly an update on the company’s financing activity and capital structure. Therefore it fits the “Capital/Financing Update” category (CAP).
2025-01-29 English
News release - English.pdf
Capital/Financing Update Classification · 88% confidence The document is a corporate news release announcing the closing of a non-brokered private placement (financing of units and warrants for gross proceeds) and describing a debt settlement involving issuance of shares. It details fundraising activity, terms of the offering, use of proceeds and related party exemptions – fitting squarely under “Capital/Financing Update.”
2025-01-29 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a non-brokered private placement (issuing common shares and warrants) and a debt settlement transaction. It provides details on unit composition, pricing, insider participation exemptions, use of proceeds, hold periods, and expected closing dates—all characteristics of a financing/capital structure update. This fits the “Capital/Financing Update” category.
2025-01-18 English
News release - English.pdf
Regulatory Filings Classification · 35% confidence The document is a corporate press release announcing the dosing of first patients in a clinical trial of natural psilocybin. It contains no financial results, no regulatory form references, no management changes, no voting outcomes, and no report attachments. It does not match any specific filing category (e.g., earnings release, annual report, management change, proxy materials, etc.). Therefore, it falls into the general/other category for miscellaneous announcements: Regulatory Filings (RNS).
2025-01-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.